{"id":4874,"date":"2024-06-11T11:51:35","date_gmt":"2024-06-11T11:51:35","guid":{"rendered":"https:\/\/regensight.com\/new-publication-on-regensight-a-clear-future-for-young-people-with-keratoconus\/"},"modified":"2024-06-11T11:52:17","modified_gmt":"2024-06-11T11:52:17","slug":"new-publication-on-regensight-a-clear-future-for-young-people-with-keratoconus","status":"publish","type":"post","link":"https:\/\/regensight.com\/en\/new-publication-regensight-a-clear-future-for-young-patients-with-keratoconus\/","title":{"rendered":"New Publication on Regensight: A Clear Future for Young People with Keratoconus"},"content":{"rendered":"\n<p>We are excited to announce the publication of a new scientific article, entitled &#8220;<strong><em>Spatial targeted delivery of riboflavin with a controlled corneal iontophoresis delivery system in theranostic-guided UV-A light photo-therapy<\/em><\/strong>&#8220;, in the prestigious <a rel=\"noreferrer noopener\" href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbio.202400068\" target=\"_blank\">Journal of Biophotonics<\/a>. <\/p>\n\n\n\n<p>This groundbreaking study explores how Regensight&#8217;s theranostic platform, which incorporates a <strong>corneal iontophoresis system<\/strong> integrated with the theranostic UV-A device, <strong>C4V CHROMO4VIS<\/strong>, to control the application of riboflavin (<strong>RitSight<\/strong>) into the cornea is transforming the treatment of keratoconus to the great benefit of young patients. <\/p>\n\n\n\n<p><strong>Regensight&#8217;s theranostic platform<\/strong> enables controlled distribution of riboflavin into the cornea with a constant concentration gradient between the central and peripheral regions. The theranostic-guided UV-A light irradiation induces <strong>significant and highly repeatable flattening in corneal topography<\/strong>, demonstrating how Regensight&#8217;s technology provides <strong>precise <\/strong>and<strong> predictive<\/strong> reshpaing of the human cornea.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are excited to announce the publication of a new scientific article, entitled &#8220;Spatial targeted delivery of riboflavin with a controlled corneal iontophoresis delivery system in theranostic-guided UV-A light photo-therapy&#8220;, in the prestigious Journal of Biophotonics. This groundbreaking study explores how Regensight&#8217;s theranostic platform, which incorporates a corneal iontophoresis system integrated with the theranostic UV-A [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":4872,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":""},"categories":[35],"tags":[69,70,44],"_links":{"self":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4874"}],"collection":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/comments?post=4874"}],"version-history":[{"count":2,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4874\/revisions"}],"predecessor-version":[{"id":4876,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/4874\/revisions\/4876"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media\/4872"}],"wp:attachment":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media?parent=4874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/categories?post=4874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/tags?post=4874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}